Prometheus Biosciences, Inc.
生物技术研究
San Diego,California 8,127 位关注者
Revolutionizing medicine with precision.
关于我们
We’re a different kind of biotech company. And we’re here to make a difference. Prometheus Biosciences, Inc. (Nasdaq: RXDX), is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases. The Company’s precision medicine platform, Prometheus360?, combines proprietary machine learning-based analytical approaches with one of the world’s largest gastrointestinal bioinformatics databases to identify novel therapeutic targets and develop therapeutic candidates to engage those targets. Prometheus Biosciences was named Best Places to Work by Biospace in 2022 and is headquartered in San Diego, CA.
- 网站
-
https://www.prometheusbiosciences.com
Prometheus Biosciences, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- San Diego,California
- 类型
- 上市公司
- 创立
- 1995
- 领域
- Bioinformatics、Data Science、diagnostics、therapeutics和precision medicine
地点
-
主要
3050 Science Park Rd
US,California,San Diego,92121
Prometheus Biosciences, Inc.员工
-
Patricia McNeeley
-
Helen C. Hutchison Adams
Lead Independent Director and Audit Committee Chair at Immix Bio (NASDAQ: IMMX), Nexcella Inc Corporate Directors’ Forum - 2023 Director of the Year…
-
Mary Szela
CEO and President at TriSalus Life Sciences
-
Marie Fiorino, MS, MBA
Pre-Clinical Pharmacology Consultant at Prec